Your browser doesn't support javascript.
loading
Twelve-month outcomes of ranibizumab versus aflibercept for macular oedema in branch retinal vein occlusion: data from the FRB! registry.
Hunt, Adrian R; Nguyen, Vuong; Creuzot-Garcher, Catherine P; Alforja, Socorro; Gabrielle, Pierre-Henry; Zarranz-Ventura, Javier; Guillemin, Martin; Fraser-Bell, Samantha; Casaroli Marano, Ricardo P; Arnold, Jennifer; McAllister, Ian L; O'Toole, Louise; Gillies, Mark C; Barthelmes, Daniel; Mehta, Hemal.
Afiliação
  • Hunt AR; Medical Retina, Westmead Hospital, Westmead, New South Wales, Australia adrianhunt@eyesurgeonsmiranda.com.au.
  • Nguyen V; Save Sight Institute, University of Sydney, Sydney, New South Wales, Australia.
  • Creuzot-Garcher CP; Clinical Ophthalmology & Eye Health, The University of Sydney, Sydney, New South Wales, Australia.
  • Alforja S; Ophthalmology, Centre Hospitalier Universitaire de Dijon, Dijon, Bourgogne, France.
  • Gabrielle PH; Institut Clínic de Oftalmologia (ICOF), Hospital Clinic de Barcelona, Barcelona, Spain.
  • Zarranz-Ventura J; Ophthalmology, Centre Hospitalier Universitaire de Dijon, Dijon, Bourgogne, France.
  • Guillemin M; Eye and Nutrition Research Group, Centre des Sciences du Goût et de l'Alimentation, INRA Centre de Dijon, Dijon, Bourgogne, France.
  • Fraser-Bell S; Institut Clínic de Oftalmologia (ICOF), Hospital Clinic de Barcelona, Barcelona, Spain.
  • Casaroli Marano RP; Ophthalmology, Centre Hospitalier Universitaire de Dijon, Dijon, Bourgogne, France.
  • Arnold J; Clinical Ophthalmology & Eye Health, The University of Sydney, Sydney, New South Wales, Australia.
  • McAllister IL; Institut Clínic de Oftalmologia (ICOF), Hospital Clinic de Barcelona, Barcelona, Spain.
  • O'Toole L; Marsden Eys Specialists, Parramatta, Greater Western Sydney, Australia.
  • Gillies MC; Lions Eye Institute, The University of Western Australia, Nedlands, Western Australia, Australia.
  • Barthelmes D; The Mater Private Hospital, Dublin, Leinster, Ireland.
  • Mehta H; Save Sight Institute, University of Sydney, Sydney, New South Wales, Australia.
Br J Ophthalmol ; 106(8): 1178-1184, 2022 08.
Article em En | MEDLINE | ID: mdl-33712484
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Recombinantes de Fusão / Oclusão da Veia Retiniana / Edema Macular / Inibidores da Angiogênese / Receptores de Fatores de Crescimento do Endotélio Vascular / Ranibizumab Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies Limite: Humans Idioma: En Revista: Br J Ophthalmol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Austrália
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Recombinantes de Fusão / Oclusão da Veia Retiniana / Edema Macular / Inibidores da Angiogênese / Receptores de Fatores de Crescimento do Endotélio Vascular / Ranibizumab Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies Limite: Humans Idioma: En Revista: Br J Ophthalmol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Austrália